Prot #M12-555: A Phase 3 Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa – PIONEER (OPEN-LABEL EXTENSION)

  • Gordon, Kenneth B (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/10/13 → 12/10/19

Funding

  • AbbVie Inc. (Prot #M12-555)